The estrogen patch shortage, explained — and what to use instead

How bad is the estrogen patch shortage right now?

Worse than when it started, and broader than the U.S. By late June 2026, CNBC reported that all five American estradiol-patch manufacturers were producing at full capacity and still could not meet demand, with the squeeze described as a worldwide problem rather than a purely American one. A Midi Health survey of roughly 8,000 women across 49 states found about half were struggling to fill their estradiol patch— a scale that turns "my pharmacy is out" into a national access problem. On ASHP's drug-shortage tracker, manufacturer recovery estimates for several high-volume patches — Amneal's Dotti, Viatris's Lyllana, and Noven's Vivelle-Dot — run into late 2026. Through all of it, the FDA has declined to declare a formal shortage, which keeps some supply-management tools (like eased importation or compounding allowances) off the table.

Sources: CNBC, June 26, 2026 (full-capacity manufacturers, worldwide scope, Midi Health survey); ASHP drug-shortage tracker (estradiol transdermal system, id 1206) (product-level backorder estimates); ongoing coverage via NBC News and NPR, March 2026.

Is there an estrogen patch shortage in 2026?

It depends who you ask — and that gap is the whole story. ASHP began listing estradiol transdermal patches as in shortage in January 2026, and by May its list had grown to more than a dozen brands and dosages. ASHP's data is reported directly by pharmacists, physicians, nurses, and patients. The FDA, which only designates a shortage when supply fails to meet a formal demand threshold, has notadded estradiol patches to its database. FDA Commissioner Dr. Marty Makary said the November 2025 black-box-warning removal "prompted a tremendous increase in demand… but not enough to cause a shortage," calling it "something to manage." So the accurate framing is not "the FDA denies a problem" — it is that the regulator has not formally designated a shortage while front-line pharmacies and patients are clearly struggling to fill prescriptions.

Source: NBC News, May 10, 2026 (FDA Commissioner Makary quotes; ASHP estradiol transdermal system shortage list).

Why can't I fill my estrogen patch?

A demand spike collided with limited manufacturing. In November 2025 the FDA began removing its strongest (black-box) warnings from menopausal hormone therapy products, with labeling changes approved in February 2026 — and prescribing surged. By February 2026, about 5% of women aged 45–54 (one in twenty) had an estrogen-based HRT prescription, and estrogen-patch prescriptions were up 184% since 2018, including a 25.7% jump in just July 2025–February 2026, per Truveta's analysis of 130 million+ patient records. (Reuters described the recent climb as a rough doubling since 2023.) Multiple estradiol patch products from Amneal, Zydus, Sandoz, Noven and Viatrisnow have doses on the ASHP shortage list — including Amneal's Dotti, one of the most-prescribed patches. Some manufacturers say they are increasing supply.

Source: Truveta, April 9, 2026 (prescription trends); manufacturer list via ASHP / NBC News / Reuters.

How long will the estrogen patch shortage last?

Nobody knows precisely, and the public estimates disagree. Anonymous industry sources told Reuters the squeeze could last up to three years— a worst case from unnamed sources, not the FDA and not a named manufacturer, but one that looks less extreme now that all five U.S. manufacturers are already at full capacity and several brands carry backorder estimates into late 2026. Named menopause experts are more measured: Mayo Clinic's Dr. Stephanie Faubion, medical director of The Menopause Society, expects supply to improve by the end of 2026 as manufacturers scale up. The honest read as of July 2026: tight through at least the end of 2026, with real uncertainty beyond that, and a worldwide supply picture rather than a purely U.S. one. We update this page as it changes.

Source: NBC News / Reuters, April 9, 2026 ("up to three years"); Dr. Faubion via NBC News, May 10, 2026.

What can I use instead of an estrogen patch?

Clinicians quoted by NBC News describe several FDA-approved routes when a patch is short. These are options to discuss with your prescriber, not recommendations:

• Switch patch brand: a different estradiol patch (or generic) may be in stock when yours isn't.
• Two lower-dose patches: combining lower strengths to reach your usual dose.
• Switch patch schedule: moving between once-weekly and twice-weekly patch types.
• Other estrogen forms: topical gel, cream, or spray; oral tablets; or a vaginal ring (which can deliver localized or systemic estrogen). Gels, creams, sprays and patches are all transdermal estrogen and clinicians quoted by NBC consider them comparable on safety — but non-patch forms are often less likely to be covered by insurance.

Two cautions worth raising with your clinician: oral estrogen carries a small added clotting risk and is generally avoided in women with a history of blood clots; and compounded "bioidentical" HRT is not an FDA-approved substitute — The Menopause Society cautions against it because of the lack of FDA oversight, and the experts quoted in the reporting did not recommend it as a first-line workaround.

Source: Dr. Stephanie Faubion (Mayo Clinic / The Menopause Society) and Dr. Lauren Streicher (Northwestern Feinberg), via NBC News, May 10, 2026.

Which telehealth providers can prescribe a patch alternative?

If your patch is unavailable and you want a clinician who can prescribe a non-patch estrogen route (gel, cream, spray, oral, or vaginal), here are the platforms on our list that offer those forms — ordered by our methodology score, not by who pays us. Each clinician decides what is appropriate for you. For a form-by-form breakdown of who ships what, use the Estradiol Patch Alternative Tracker.

We earn a commission when readers sign up with some of these platforms — disclosed on every page and never a factor in the score. Compare all options on the full rankings or estimate cost with the HRT cost calculator.

This is general information, not medical advice. HRT is a prescription medical treatment; whether and how to switch estrogen forms depends on your health history and must be decided with a licensed clinician. HRT Picks is not a medical provider and has no role in your care. Figures on this page were verified against the primary sources cited above on July 6, 2026, and we update the shortage status as it changes.